Not all older adults can get monoclonal antibodies for Alzheimer’s disease, study finds
By
Kristen Fischer
Sep 22, 2023
Even though newer monoclonal antibodies are available for Alzheimer’s disease, there are limits on the number of older adults who can receive them, a recent study published in Neurology finds.
Clinical briefs for Tuesday, Sept. 19
By
Kristen Fischer
Sep 19, 2023
Here’s how many nursing homes can meet proposed staffing requirements … Slim reimbursement for lumbar puncture an obstacle for Alzheimer’s care … Health, food policies could aid antimicrobial resistance...
Clinical briefs for Tuesday, Sept. 12
By
Kristen Fischer
Sep 12, 2023
Feds make deal with Regeneron on more COVID-19 monoclonal antibodies … These “secrets” help people in blue zones live longer … What it’ll take to make Alzheimer’s blood tests routine … Study...
Clinical briefs for Friday, Sept. 8
By
Kristen Fischer
Sep 08, 2023
Study: Cognition and function decline at similar rates in dementia … There are 7 things doctors can do to improve care for older adults … FDA approves Illaris for gout after failed attempts … Up...
Clinical briefs for Friday, Sept. 1
By
Kristen Fischer
Sep 01, 2023
Gene seems to protect some from Alzheimer’s, Parkinson’s … Sweating, seizure activity common day before heart attack … SSRIs can up arrhythmia risk in some people … Probiotics improve...
Clinical briefs for Thursday, Aug. 24
By
Kristen Fischer
Aug 24, 2023
Headband tests brain activity for Alzheimer’s during sleep … Dementia, death risk lower with catheter ablation … Opioids up fracture risk in older adults with ankylosing spondylitis … Recognizing...
Clinical briefs for Tuesday, Aug. 22
By
Kristen Fischer
Aug 21, 2023
FDA gives OK to higher dose of eye disease drug … Shingles, pneumonia shots may lower Alzheimer’s risk … More findings on the Parkinson’s, gut link … Being bilingual may offer a memory perk...
FDA fast-tracked dementia drug with known harms, reporter says
By
Kristen Fischer
Aug 18, 2023
An article in The BMJ is sounding the alarm that the US Food and Drug Administration fast-tracked approval for the dementia drug Rexulti (brexpiprazole) — even though trials show the drug is harmful.
Clinical briefs for Thursday, Aug. 17
By
Kristen Fischer
Aug 17, 2023
COVID shots in the same arm may give better immunity … Mild cognitive impairment linked to weaker decision-making … Older women with Parkinson’s disease aren’t exercising enough … FDA approves...
Brains of people with Alzheimer’s are low on some antioxidants, study finds
By
Kristen Fischer
Aug 16, 2023
People with Alzheimer’s disease have half the levels of certain antioxidants compared to people without the disease, according to a new study.